Cancer burden of major cancers in China: A need for sustainable actions-Reference-Cited by-同舟云学术

Cancer burden of major cancers in China: A need for sustainable actions

Published:2020-05 Issue:5 Volume:40 Page:205-210
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Cao Maomao¹,Li He¹,Sun Dianqin¹,Chen Wanqing¹

Affiliation:

1. Office of Cancer ScreeningNational Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021 P. R. China

Funder

Sanming Project of Medicine in Shenzhen

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cac2.12025

Reference35 articles.

1. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?

2. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

3. FerlayJ ErvikM LamF ColombetM MeryL PiñerosMet al.Global Cancer Observatory: Cancer Today. Lyon France: International Agency for Research on Cancer.2018.https://gco.iarc.fr/today(accessed Nov 15 2019). Accessed 8 144.

4. Cancer statistics, 2020

5. Report of cancer epidemiology in China, 2015;Zheng R;Chin J Oncol,2019

Cited by 310 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Factors Influencing Hospitalization Expenses of Patients with Gastric Cancer in Shanghai, 2014-2021: Based on Grey Relational Analysis and Structural Equation Modeling;Value in Health Regional Issues;2024-11

2. IL-6/STAT3 signaling pathway induces prostate apoptosis response protein-4(PAR-4) to stimulate malignant behaviors of hepatocellular carcinoma cells;Annals of Hepatology;2024-11

3. Highly expressed B3GALT5‐AS1 contributes to gastric cancer progression by recruiting WDR5 to mediate B3GALT5 and regulating β‐catenin/ZEB1 axis;Journal of Cellular and Molecular Medicine;2024-09

4. MiR-3074-5p suppresses non-small cell lung cancer progression by targeting the YWHAZ/Hsp27 axis;International Immunopharmacology;2024-09

5. Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products;Phytomedicine;2024-09